Question 1

Does Ubs own OCUL stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Ubs holds 1,551,001 shares of OCUL (Ocular Therapeutix), worth $15.2M.

Question 2

How many shares of OCUL does Ubs own?

Accepted Answer

As of its Q2 2026 13F, Ubs holds 1,551,001 shares of OCUL (Ocular Therapeutix).

Question 3

What is Ubs' OCUL position worth?

Accepted Answer

As of its Q2 2026 13F, Ubs' OCUL position is worth $15.2M.

Question 4

Is Ubs buying or selling OCUL?

Accepted Answer

In Q2 2026, Ubs increased its OCUL position by 30,370 shares (+2.0%).

Question 5

When did Ubs first buy OCUL?

Accepted Answer

Ubs already held OCUL in its Q1 2019 13F, the earliest on record, and has listed it in 30 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	1.6M	+2.0%	$15.2M	0.0%	$9.82	29
2026-Q1	Increased	1.5M	+22.1%	$12.9M	0.0%	$8.47	34
2025-Q4	Decreased	1.2M	-0.3%	$15.1M	0.0%	$12.14	0
2025-Q3	Decreased	1.2M	-36.5%	$14.6M	0.0%	$11.69	0
2025-Q2	Increased	2M	+47.2%	$18.2M	0.0%	$9.28	39
2025-Q1	Increased	1.3M	+52.3%	$9.8M	0.0%	$7.33	39
2024-Q4	Increased	876,546	+28.0%	$7.5M	0.0%	$8.54	34
2024-Q3	Decreased	684,776	-8.5%	$6M	0.0%	$8.70	0

OCULShowing 8 of 30 quarters

OCUL
Showing 8 of 30 quarters